The Iliac/SFA/Popliteal Center

Filter Your Results




AngioScore Launches Longer AngioSculpt Balloon Catheters

April 1, 2011—AngioScore, Inc. (Fremont, CA) announced the launch of new, longer AngioSculpt percutaneous transluminal angioplasty (PTA) scoring balloon catheters for the tr…

An Interview With Krishna Rocha-Singh, MD

March 2011—A leading interventional cardiologist and clinical trialist discusses new advancements in vascular therapy and his thoughts on the emerging trial data.

FDA Approves Next-Generation Gore Viabahn

February 17, 2011—Gore & Associates (Flagstaff, AZ) announced that it has received US Food and Drug Administration approval for the Gore Viabahn endoprosthesis with hepa…

FSS Receives IDE Approval for Femoropopliteal Study of FlexStent

February 2, 2011—Flexible Stenting Solutions, Inc. (FSS, Eatontown, NJ) announced that the US Food and Drug Administration (FDA) has granted investigational device exemption…

Long-Term European Data Support IDev’s Supera Stent to Treat SFA

January 26, 2011—IDev Technologies, Inc. (Webster, TX) announced the release of 2-year European data from the Leipzig Registry, which tracks patients treated with the compan…

Lower-Profile Gore Viabahn Launched in Europe

January 19, 2011—At the Leipzig Interventional Course in Germany, Gore & Associates (Flagstaff, AZ) announced the European availability of the Gore Viabahn endoprosthesi…

Covidien Launches Next-Generation EverFlex+ Peripheral Stent System in Europe

January 18, 2011—Covidien (Mansfield, MA) announced the European launch of the EverFlex+ nitinol self-expanding peripheral stent system for the treatment of peripheral arter…

Cook Medical's 2-Year Zilver PTX Trial Results Presented at ISET

January 17, 2011—Cook Medical (Bloomington, IN) announced that principal investigator Michael Dake, MD, presented 2-year results of the Zilver PTX trial at the International…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.